查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2026879

2034年關節疼痛注射藥物市場預測－按關節類型、注射類型、通路、最終用戶和地區分類的全球分析

Joint Pain Injections Market Forecasts to 2034 - Global Analysis By Joint Type (Shoulder and Elbow, Facet Joints of the Spine, Knee and Ankle, Hip Joint and Other Joint Types), Injection Type, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 預測，到 2026 年，全球關節痛注射劑市場規模預計將達到 70.4 億美元，在預測期內以 10.6% 的複合年成長率成長，到 2034 年將達到 157.6 億美元。

關節內注射藥物可透過減輕腫脹和發炎來治療關節疼痛。老年人的關節不適通常是由潛在疾病引起的。這種疾病俗稱關節炎，主要影響髖關節、膝關節、肘關節和肩關節，以及脊椎的椎間關節。它會導致關節炎症，從而引起不適。

根據英國關節炎研究協會發布的《2018 年肌肉骨骼健康狀況》報告，英國估計有 1,780 萬人患有肌肉骨骼疾病，約佔全國總人口的 28.9%。

關節炎加重

在全球範圍內，關節炎是導致成人殘疾的主要原因。例如，注射皮質類固醇和透明質酸可以透過潤滑關節和減輕炎症，顯著緩解疼痛、僵硬和不適。透過將藥物精準注射到疼痛或發炎部位，注射可以有效地針對受累關節，從而提高療效並最大限度地減少全身副作用。這些因素正在推動市場成長。

副作用和過敏反應

關節痛注射療法的副作用和過敏反應已成為市場擴張的主要障礙。一些接受注射的患者出現了軟骨和神經損傷，這影響了此類醫療設備的生產和銷售。此外，患者使用注射劑後可能出現的皮膚變色和感染疾病也被認為是該行業擴張的最大障礙。

關節相關疾病盛行率增加

關節相關疾病的日益普遍是成長要素之一。骨關節炎和類風濕性關節炎等疾病發生率的上升，使得包括關節疼痛注射在內的有效疼痛管理方案的需求顯著增加。人口老化、久坐的生活方式以及運動傷害也是推動市場成長的因素。

缺乏知識

大多數人從未聽說過關節疼痛注射療法。富血小板血漿（PRP）、皮質類固醇和玻尿酸注射療法可用於緩解關節不適。進行這些注射需要高超的專業技能和訓練。醫生和其他醫療保健專業人員經常會進行關節疼痛注射治療。相關設備和專業人員培訓均已到位。然而，由於缺乏政府政策來推廣關節疼痛注射療法，限制了市場成長。

新型冠狀病毒（COVID-19）的影響：

新冠肺炎疫情是一場前所未有的全球公共衛生災難，幾乎影響了所有企業，預計其影響將在整個預測期內持續衝擊各行各業的成長。在全球範圍內，供應鏈中斷、採購模式、客戶需求和行為以及關鍵政府措施都發生了許多變化。疫情改變了人們的生活方式、藥物使用習慣和其他健康相關習慣。

在預測期內，玻尿酸注射市場預計將成為最大的細分市場。

在預測期內，透明質酸注射劑市場預計將佔據最大佔有率。一些嘗試過對乙醯胺酚和其他鴉片類藥物等無效治療方法的患者，正在接受透明質酸注射劑治療與骨關節炎相關的膝關節疼痛。透明質酸注射劑作為一種非手術治療方法，正逐漸獲得認可，特別是因為醫生通常不願意常規進行關節內皮質類固醇注射。

在預測期內，醫院藥房細分市場預計將呈現最高的複合年成長率。

在預測期內，醫院藥房領域預計將呈現最高的複合年成長率。醫院藥局通常不僅聘用合格的藥劑師，還聘用接受過注射給藥專業培訓的醫護人員，這確保了正確的給藥技術並降低了併發症的風險。患者可以獲得更廣泛的疼痛管理方案，包括各種類型的注射劑和根據其特定需求量身定做的聯合治療。

市佔率最大的地區：

由於北美地區肌肉骨骼疾病高發生且老年人口不斷成長，預計該地區在預測期內將佔據最大的市場佔有率。這歸因於多種因素，包括市場參與企業集中於該地區、行業參與者實力雄厚、醫療基礎設施完善，以及公眾和行業相關人員對現有技術的了解。該地區的市場也在不斷擴張，部分原因是其對最尖端科技的較高採用率。

複合年成長率最高的地區：

預計亞太地區在預測期內將維持最高的複合年成長率。骨關節炎盛行率的上升以及區域競爭對手進入黏彈性移植物市場是推動各國市場成長的主要因素。此外，該地區對尖端關節疼痛治療方法的了解不斷加深，也為患者接受這些治療方法創造了理想的環境。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域分類
    • 應客戶要求，我們提供主要國家和地區的市場估算和預測，以及複合年成長率（註：需進行可行性檢查）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對重點公司進行基準分析。

目錄

第1章執行摘要

第2章：引言

  • 概括
  • 相關利益者
  • 調查範圍
  • 調查方法
  • 研究材料

第3章 市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因子
  • 機會
  • 威脅
  • 最終用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章：波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭

第5章：全球關節疼痛注射市場：以關節類型分類

  • 肩部和肘部
  • 脊椎的椎間關節
  • 膝蓋和腳踝
  • 髖關節
  • 其他關節

第6章：全球關節疼痛注射劑市場：依注射類型分類

  • 白細胞介素抑制劑
  • 玻尿酸注射
  • 類固醇關節注射
  • 富血小板血漿（PRP）注射
  • 胎盤組織基質（PTM）注射
  • 其他類型的注射

第7章 全球注射式關節疼痛市場：依通路分類

  • 零售藥房
  • 醫院藥房
  • 網路藥房

第8章：全球注射式關節疼痛市場：依最終用戶分類

  • 醫院
  • 診所
  • 其他最終用戶

第9章 全球關節疼痛注射劑市場：按地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太國家
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 卡達
    • 南非
    • 其他中東和非洲國家

第10章 主要發展

  • 合約、夥伴關係、合作關係、合資企業
  • 收購與併購
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章：公司簡介

  • Anika Therapeutics, Inc.
  • Sanofi aventis LLC
  • Ferring BV
  • Zimmer Biomet
  • Bioventus LLC
  • Allergen Plc.
  • Pfizer Inc.
  • Chugai Pharmaceutical Co. Ltd
  • SEIKAGAKU Corporation
  • Ferring BV
  • Pacira Biosciences
  • OrthogenRx
  • Pfizer
  • Lifecore Biomedical
  • Wright Medical Group
  • AbbVie
  • Stryker
Product Code: SMRC24640

According to Stratistics MRC, the Global Joint Pain Injections Market is accounted for $7.04 billion in 2026 and is expected to reach $15.76 billion by 2034 growing at a CAGR of 10.6% during the forecast period. Direct injections into the joints are used to treat joint pain in order to reduce swelling and inflammation. In the elderly population, joint discomfort is typically brought on by pre-existing conditions. The widespread ailment known as arthritis mostly affects the hip, knee, elbow, shoulder, and facet joints of the spine. It causes inflammation in the joints and makes them uncomfortable.

According to the Arthritis Research UK report, "The State of Musculoskeletal Health 2018", it is estimated that 17.8 million people suffer with a musculoskeletal condition in the UK which is around 28.9% of the total population of the country.

Market Dynamics:

Driver:

Increased occurrence of arthritis

The most frequent cause of adult disability worldwide is arthritis. Corticosteroids and hyaluronic acid injections, for example, can significantly reduce pain by lubricating the joints and decreasing inflammation, which relieves stiffness and discomfort. By carefully administering medicine to the region of pain or inflammation, injections target the afflicted joint, increasing efficacy and minimizing systemic adverse effects. The market is expanding as a result of these causes.

Restraint:

Side effects and allergies

Joint pain injection side effects and allergies that patients experienced have turned out to be a significant barrier to the market's expansion. Some patients who had joint pain injections had damage to their cartilage and nerves, which has had an impact on the manufacturing and marketing of these medical devices. Furthermore, the largest obstacle to the industry's expansion has been shown to be skin discoloration and infections that result from patients using joint pain inoculations.

Opportunity:

Growing prevalence of joint-related disorders

One driver of the market is the growing prevalence of joint-related disorders. The increasing incidence of conditions such as osteoarthritis and rheumatoid arthritis has created a substantial demand for effective pain management solutions, including joint pain injections. The rising aging population, sedentary lifestyles, and sports-related injuries further contribute to the market growth.

Threat:

Lack of knowledge

The average population has never heard about joint pain injections. Platelet-rich plasma, corticosteroids, and hyaluronic acid injections are used to relieve joint discomfort. To utilize these injections, one must possess a great deal of expertise and training. Physicians and other medical professionals frequently inject people for joint discomfort. The tools and training needed for professionals to do this are supplied. The lack of government measures to encourage joint pain injections, however, limits the market's growth.

Covid-19 Impact:

The COVID-19 pandemic has turned out to be an unparalleled worldwide public health disaster that has impacted practically every business, and its repercussions are anticipated to have an impact on every industry's growth over the projection period. Globally, there have been several shifts in supply chain rerouting, purchasing patterns, customer demand and behavior, and major government efforts. The epidemic has altered people's lifestyles, drug usage patterns, and other health-related habits.

The hyaluronic acid injections segment is expected to be the largest during the forecast period

The hyaluronic acid injections segment is expected to be the largest during the forecast period. Patients who have already tried ineffective treatments like acetaminophen and other opioids are treated with hyaluronic acid injections for knee discomfort associated with osteoarthritis. Injections of hyaluronic acid have grown in favor as a non-surgical treatment option, especially considering that physicians are generally reluctant to administer intraarticular corticosteroid injections on a regular basis.

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period

The hospital pharmacies segment is expected to have the highest CAGR during the forecast period. Hospital pharmacies frequently employ medical professionals with specific training in injectable administration in addition to competent pharmacists, assuring correct technique and lowering the chance of problems. Patients have access to a wider range of pain management options, including different types of injections or combination therapies tailored to their specific needs.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the high prevalence of musculoskeletal disorders, growing geriatric population. This is ascribed to a number of factors, including the large concentration of market participants in the area, the robust presence of industry companies in the area, improved healthcare infrastructure, and public and industry stakeholder knowledge of available technology. The market in this area is expanding due in part to a high rate of adoption of cutting-edge technology.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period. The rising incidence of osteoarthritis and the entry of viscosupplement products by regional competitors are propelling the growth of the respective markets in each country. Furthermore, ideal circumstances for the patient population's acceptance of these therapies are created by the growing knowledge of cutting-edge joint pain treatments in the area.

Key players in the market

Some of the key players in Joint Pain Injections market include Anika Therapeutics, Inc., Sanofi aventis LLC, Ferring B.V., Zimmer Biomet, Bioventus LLC, Allergen Plc., Pfizer Inc., Chugai Pharmaceutical Co. Ltd, SEIKAGAKU Corporation, Ferring B.V., Pacira Biosciences, OrthogenRx, Pfizer, Lifecore Biomedical, Wright Medical Group, AbbVie and Stryker.

Key Developments:

In January 2023, AbbVie received the United States Food and Drug Administration (FDA) approval for SKYRIZI (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), which can be administered with a single injection four times a year.

In March 2022, Sanofi collaborated with IGM Biosciences Inc. to develop, manufacture, and introduce potential therapeutics in the fields of immunology and inflammation.

Joint Types Covered:

  • Shoulder and Elbow
  • Facet Joints of the Spine
  • Knee and Ankle
  • Hip Joint
  • Other Joint Types

Injection Types Covered:

  • Interleukin Inhibitors
  • Hyaluronic Acid Injections
  • Steroid Joint Injections
  • Platelet-rich Plasma (PRP) Injections
  • Placental Tissue Matrix (PTM) Injections
  • Other Injection Types

Distribution Channels Covered:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

End Users Covered:

  • Hospitals
  • Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introducton
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Joint Pain Injections Market, By Joint Type

  • 5.1 Introduction
  • 5.2 Shoulder and Elbow
  • 5.3 Facet Joints of the Spine
  • 5.4 Knee and Ankle
  • 5.5 Hip Joint
  • 5.6 Other Joint Types

6 Global Joint Pain Injections Market, By Injection Type

  • 6.1 Introduction
  • 6.2 Interleukin Inhibitors
  • 6.3 Hyaluronic Acid Injections
  • 6.4 Steroid Joint Injections
  • 6.5 Platelet-rich Plasma (PRP) Injections
  • 6.6 Placental Tissue Matrix (PTM) Injections
  • 6.7 Other Injection Types

7 Global Joint Pain Injections Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Retail Pharmacies
  • 7.3 Hospital Pharmacies
  • 7.4 Online Pharmacies

8 Global Joint Pain Injections Market, By End User

  • 8.1 Introduction
  • 8.2 Hospitals
  • 8.3 Clinics
  • 8.4 Other End Users

9 Global Joint Pain Injections Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Anika Therapeutics, Inc.
  • 11.2 Sanofi aventis LLC
  • 11.3 Ferring B.V.
  • 11.4 Zimmer Biomet
  • 11.5 Bioventus LLC
  • 11.6 Allergen Plc.
  • 11.7 Pfizer Inc.
  • 11.8 Chugai Pharmaceutical Co. Ltd
  • 11.9 SEIKAGAKU Corporation
  • 11.10 Ferring B.V.
  • 11.11 Pacira Biosciences
  • 11.12 OrthogenRx
  • 11.13 Pfizer
  • 11.14 Lifecore Biomedical
  • 11.15 Wright Medical Group
  • 11.16 AbbVie
  • 11.17 Stryker

List of Tables

  • Table 1 Global Joint Pain Injections Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Joint Pain Injections Market Outlook, By Joint Type (2023-2034) ($MN)
  • Table 3 Global Joint Pain Injections Market Outlook, By Shoulder and Elbow (2023-2034) ($MN)
  • Table 4 Global Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2023-2034) ($MN)
  • Table 5 Global Joint Pain Injections Market Outlook, By Knee and Ankle (2023-2034) ($MN)
  • Table 6 Global Joint Pain Injections Market Outlook, By Hip Joint (2023-2034) ($MN)
  • Table 7 Global Joint Pain Injections Market Outlook, By Other Joint Types (2023-2034) ($MN)
  • Table 8 Global Joint Pain Injections Market Outlook, By Injection Type (2023-2034) ($MN)
  • Table 9 Global Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2023-2034) ($MN)
  • Table 10 Global Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2023-2034) ($MN)
  • Table 11 Global Joint Pain Injections Market Outlook, By Steroid Joint Injections (2023-2034) ($MN)
  • Table 12 Global Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2023-2034) ($MN)
  • Table 13 Global Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2023-2034) ($MN)
  • Table 14 Global Joint Pain Injections Market Outlook, By Other Injection Types (2023-2034) ($MN)
  • Table 15 Global Joint Pain Injections Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 16 Global Joint Pain Injections Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 17 Global Joint Pain Injections Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 18 Global Joint Pain Injections Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 19 Global Joint Pain Injections Market Outlook, By End User (2023-2034) ($MN)
  • Table 20 Global Joint Pain Injections Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 21 Global Joint Pain Injections Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 22 Global Joint Pain Injections Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 23 North America Joint Pain Injections Market Outlook, By Country (2023-2034) ($MN)
  • Table 24 North America Joint Pain Injections Market Outlook, By Joint Type (2023-2034) ($MN)
  • Table 25 North America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2023-2034) ($MN)
  • Table 26 North America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2023-2034) ($MN)
  • Table 27 North America Joint Pain Injections Market Outlook, By Knee and Ankle (2023-2034) ($MN)
  • Table 28 North America Joint Pain Injections Market Outlook, By Hip Joint (2023-2034) ($MN)
  • Table 29 North America Joint Pain Injections Market Outlook, By Other Joint Types (2023-2034) ($MN)
  • Table 30 North America Joint Pain Injections Market Outlook, By Injection Type (2023-2034) ($MN)
  • Table 31 North America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2023-2034) ($MN)
  • Table 32 North America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2023-2034) ($MN)
  • Table 33 North America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2023-2034) ($MN)
  • Table 34 North America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2023-2034) ($MN)
  • Table 35 North America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2023-2034) ($MN)
  • Table 36 North America Joint Pain Injections Market Outlook, By Other Injection Types (2023-2034) ($MN)
  • Table 37 North America Joint Pain Injections Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 38 North America Joint Pain Injections Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 39 North America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 40 North America Joint Pain Injections Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 41 North America Joint Pain Injections Market Outlook, By End User (2023-2034) ($MN)
  • Table 42 North America Joint Pain Injections Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 43 North America Joint Pain Injections Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 44 North America Joint Pain Injections Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 45 Europe Joint Pain Injections Market Outlook, By Country (2023-2034) ($MN)
  • Table 46 Europe Joint Pain Injections Market Outlook, By Joint Type (2023-2034) ($MN)
  • Table 47 Europe Joint Pain Injections Market Outlook, By Shoulder and Elbow (2023-2034) ($MN)
  • Table 48 Europe Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2023-2034) ($MN)
  • Table 49 Europe Joint Pain Injections Market Outlook, By Knee and Ankle (2023-2034) ($MN)
  • Table 50 Europe Joint Pain Injections Market Outlook, By Hip Joint (2023-2034) ($MN)
  • Table 51 Europe Joint Pain Injections Market Outlook, By Other Joint Types (2023-2034) ($MN)
  • Table 52 Europe Joint Pain Injections Market Outlook, By Injection Type (2023-2034) ($MN)
  • Table 53 Europe Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2023-2034) ($MN)
  • Table 54 Europe Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2023-2034) ($MN)
  • Table 55 Europe Joint Pain Injections Market Outlook, By Steroid Joint Injections (2023-2034) ($MN)
  • Table 56 Europe Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2023-2034) ($MN)
  • Table 57 Europe Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2023-2034) ($MN)
  • Table 58 Europe Joint Pain Injections Market Outlook, By Other Injection Types (2023-2034) ($MN)
  • Table 59 Europe Joint Pain Injections Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 60 Europe Joint Pain Injections Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 61 Europe Joint Pain Injections Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 62 Europe Joint Pain Injections Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 63 Europe Joint Pain Injections Market Outlook, By End User (2023-2034) ($MN)
  • Table 64 Europe Joint Pain Injections Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 65 Europe Joint Pain Injections Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 66 Europe Joint Pain Injections Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 67 Asia Pacific Joint Pain Injections Market Outlook, By Country (2023-2034) ($MN)
  • Table 68 Asia Pacific Joint Pain Injections Market Outlook, By Joint Type (2023-2034) ($MN)
  • Table 69 Asia Pacific Joint Pain Injections Market Outlook, By Shoulder and Elbow (2023-2034) ($MN)
  • Table 70 Asia Pacific Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2023-2034) ($MN)
  • Table 71 Asia Pacific Joint Pain Injections Market Outlook, By Knee and Ankle (2023-2034) ($MN)
  • Table 72 Asia Pacific Joint Pain Injections Market Outlook, By Hip Joint (2023-2034) ($MN)
  • Table 73 Asia Pacific Joint Pain Injections Market Outlook, By Other Joint Types (2023-2034) ($MN)
  • Table 74 Asia Pacific Joint Pain Injections Market Outlook, By Injection Type (2023-2034) ($MN)
  • Table 75 Asia Pacific Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2023-2034) ($MN)
  • Table 76 Asia Pacific Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2023-2034) ($MN)
  • Table 77 Asia Pacific Joint Pain Injections Market Outlook, By Steroid Joint Injections (2023-2034) ($MN)
  • Table 78 Asia Pacific Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2023-2034) ($MN)
  • Table 79 Asia Pacific Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2023-2034) ($MN)
  • Table 80 Asia Pacific Joint Pain Injections Market Outlook, By Other Injection Types (2023-2034) ($MN)
  • Table 81 Asia Pacific Joint Pain Injections Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 82 Asia Pacific Joint Pain Injections Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 83 Asia Pacific Joint Pain Injections Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 84 Asia Pacific Joint Pain Injections Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 85 Asia Pacific Joint Pain Injections Market Outlook, By End User (2023-2034) ($MN)
  • Table 86 Asia Pacific Joint Pain Injections Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 87 Asia Pacific Joint Pain Injections Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 88 Asia Pacific Joint Pain Injections Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 89 South America Joint Pain Injections Market Outlook, By Country (2023-2034) ($MN)
  • Table 90 South America Joint Pain Injections Market Outlook, By Joint Type (2023-2034) ($MN)
  • Table 91 South America Joint Pain Injections Market Outlook, By Shoulder and Elbow (2023-2034) ($MN)
  • Table 92 South America Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2023-2034) ($MN)
  • Table 93 South America Joint Pain Injections Market Outlook, By Knee and Ankle (2023-2034) ($MN)
  • Table 94 South America Joint Pain Injections Market Outlook, By Hip Joint (2023-2034) ($MN)
  • Table 95 South America Joint Pain Injections Market Outlook, By Other Joint Types (2023-2034) ($MN)
  • Table 96 South America Joint Pain Injections Market Outlook, By Injection Type (2023-2034) ($MN)
  • Table 97 South America Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2023-2034) ($MN)
  • Table 98 South America Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2023-2034) ($MN)
  • Table 99 South America Joint Pain Injections Market Outlook, By Steroid Joint Injections (2023-2034) ($MN)
  • Table 100 South America Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2023-2034) ($MN)
  • Table 101 South America Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2023-2034) ($MN)
  • Table 102 South America Joint Pain Injections Market Outlook, By Other Injection Types (2023-2034) ($MN)
  • Table 103 South America Joint Pain Injections Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 104 South America Joint Pain Injections Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 105 South America Joint Pain Injections Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 106 South America Joint Pain Injections Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 107 South America Joint Pain Injections Market Outlook, By End User (2023-2034) ($MN)
  • Table 108 South America Joint Pain Injections Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 109 South America Joint Pain Injections Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 110 South America Joint Pain Injections Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 111 Middle East & Africa Joint Pain Injections Market Outlook, By Country (2023-2034) ($MN)
  • Table 112 Middle East & Africa Joint Pain Injections Market Outlook, By Joint Type (2023-2034) ($MN)
  • Table 113 Middle East & Africa Joint Pain Injections Market Outlook, By Shoulder and Elbow (2023-2034) ($MN)
  • Table 114 Middle East & Africa Joint Pain Injections Market Outlook, By Facet Joints of the Spine (2023-2034) ($MN)
  • Table 115 Middle East & Africa Joint Pain Injections Market Outlook, By Knee and Ankle (2023-2034) ($MN)
  • Table 116 Middle East & Africa Joint Pain Injections Market Outlook, By Hip Joint (2023-2034) ($MN)
  • Table 117 Middle East & Africa Joint Pain Injections Market Outlook, By Other Joint Types (2023-2034) ($MN)
  • Table 118 Middle East & Africa Joint Pain Injections Market Outlook, By Injection Type (2023-2034) ($MN)
  • Table 119 Middle East & Africa Joint Pain Injections Market Outlook, By Interleukin Inhibitors (2023-2034) ($MN)
  • Table 120 Middle East & Africa Joint Pain Injections Market Outlook, By Hyaluronic Acid Injections (2023-2034) ($MN)
  • Table 121 Middle East & Africa Joint Pain Injections Market Outlook, By Steroid Joint Injections (2023-2034) ($MN)
  • Table 122 Middle East & Africa Joint Pain Injections Market Outlook, By Platelet-rich Plasma (PRP) Injections (2023-2034) ($MN)
  • Table 123 Middle East & Africa Joint Pain Injections Market Outlook, By Placental Tissue Matrix (PTM) Injections (2023-2034) ($MN)
  • Table 124 Middle East & Africa Joint Pain Injections Market Outlook, By Other Injection Types (2023-2034) ($MN)
  • Table 125 Middle East & Africa Joint Pain Injections Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 126 Middle East & Africa Joint Pain Injections Market Outlook, By Retail Pharmacies (2023-2034) ($MN)
  • Table 127 Middle East & Africa Joint Pain Injections Market Outlook, By Hospital Pharmacies (2023-2034) ($MN)
  • Table 128 Middle East & Africa Joint Pain Injections Market Outlook, By Online Pharmacies (2023-2034) ($MN)
  • Table 129 Middle East & Africa Joint Pain Injections Market Outlook, By End User (2023-2034) ($MN)
  • Table 130 Middle East & Africa Joint Pain Injections Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 131 Middle East & Africa Joint Pain Injections Market Outlook, By Clinics (2023-2034) ($MN)
  • Table 132 Middle East & Africa Joint Pain Injections Market Outlook, By Other End Users (2023-2034) ($MN)